RETRACTED: Mitochondrial tRNALeu(UUR) Mutations in Patients with Essential Hypertension

ORIGINAL ARTICLE
Ikram Khan, An Lizhe, Li Zhiqiang

 
International Journal of Biomedicine. 2022;12(3):444-449.
DOI: 10.21103/Article12(3)_OA18
Originally published September 5, 2022

Abstract: 

This article has been retracted.
Please see:
Editorial retraction – March 3, 2023

Arterial hypertension remains a major modifiable risk factor for cardiovascular disease. Previous studies have noted a maternal effect on blood pressure (BP). Mutations in mitochondrial DNA (mtDNA) have become an additional target of investigations on the missing BP heritability. The major objective of the present work was to investigate mutations in the tRNALeu(UUR) gene in 20 Pakistani patients with EH and compare the amplified sequences to the mitochondrial reference sequence. DNA was extracted from their saliva, and the mitochondrial tRNALeu(UUR) gene was amplified using PCR with specified primers. The present study did not find mutations in the tRNALeu(UUR) gene in Pakistani EH patients. Further studies are needed for confirmation.

Keywords: 
essential hypertension • mitochondria • tRNALeu(UUR) • mutations
References: 
  1. Mills KT, Bundy JD, Kelly TN, Reed JE, Kearney PM, Reynolds K, Chen J, He J. Global Disparities of Hypertension Prevalence and Control: A Systematic Analysis of Population-Based Studies From 90 Countries. Circulation. 2016 Aug 9;134(6):441-50. doi: 10.1161/CIRCULATIONAHA.115.018912. PMID: 27502908; PMCID: PMC4979614.
  2. Kunes J, Zicha J. Developmental windows and environment as important factors in the expression of genetic information: a cardiovascular physiologist's view. Clin Sci (Lond). 2006 Nov;111(5):295-305. doi: 10.1042/CS20050271. PMID: 17034366.
  3. Wang X, Ding X, Su S, Harshfield G, Treiber F, Snieder H. Genetic influence on blood pressure measured in the office, under laboratory stress and during real life. Hypertens Res. 2011 Feb;34(2):239-44. doi: 10.1038/hr.2010.218. Epub 2010 Nov 11. PMID: 21068740; PMCID: PMC3713474.
  4.  Wang X, Ding X, Su S, Yan W, Harshfield G, Treiber F, Snieder H. Genetic influences on daytime and night-time blood pressure: similarities and differences. J Hypertens. 2009 Dec;27(12):2358-64. doi: 10.1097/HJH.0b013e328330e84d. PMID: 19657283; PMCID: PMC3713486.
  5. Fan JB, Chen X, Halushka MK, Berno A, Huang X, Ryder T, Lipshutz RJ, Lockhart DJ, Chakravarti A. Parallel genotyping of human SNPs using generic high-density oligonucleotide tag arrays. Genome Res. 2000 Jun;10(6):853-60. doi: 10.1101/gr.10.6.853. PMID: 10854416; PMCID: PMC310915.        
  6. Oliphant A, Barker DL, Stuelpnagel JR, Chee MS. BeadArray technology: enabling an accurate, cost-effective approach to high-throughput genotyping. Biotechniques. 2002 Jun;Suppl:56-8, 60-1. PMID: 12083399.
  7. Padmanabhan S, Melander O, Johnson T, Di Blasio AM, Lee WK, Gentilini D, et al.; Global BPgen Consortium, Munroe P, Caulfield MJ, Zanchetti A, Dominiczak AF. Genome-wide association study of blood pressure extremes identifies variant near UMOD associated with hypertension. PLoS Genet. 2010 Oct
  8. Dromparis P, Michelakis ED. Mitochondria in vascular health and disease. Annu Rev Physiol. 2013;75:95-126. doi: 10.1146/annurev-physiol-030212-183804. Epub 2012 Nov 16. PMID: 23157555.
  9. Eirin A, Lerman A, Lerman LO. Mitochondria: a pathogenic paradigm in hypertensive renal disease. Hypertension. 2015 Feb;65(2):264-70. doi: 10.1161/HYPERTENSIONAHA.114.04598. Epub 2014 Nov 17. PMID: 25403611; PMCID: PMC4289015.
  10. Marian AJ. Mitochondrial genetics and human systemic hypertension. Circ Res. 2011 Apr 1;108(7):784-6. doi: 10.1161/CIRCRESAHA.111.242768. PMID: 21454791.
  11. Eirin A, Lerman A, Lerman LO. Mitochondrial injury and dysfunction in hypertension-induced cardiac damage. Eur Heart J. 2014 Dec 7;35(46):3258-66. doi: 10.1093/eurheartj/ehu436. Epub 2014 Nov 10. PMID: 25385092; PMCID: PMC4258226.
  12. Gong S, Peng Y, Jiang P, Wang M, Fan M, Wang X, Zhou H, Li H, Yan Q, Huang T, Guan MX. A deafness-associated tRNAHis mutation alters the mitochondrial function, ROS production and membrane potential. Nucleic Acids Res. 2014 Jul;42(12):8039-48. doi: 10.1093/nar/gku466. Epub 2014 Jun 11. PMID: 24920829; PMCID: PMC4081083.
  13. Wallace DC. Mitochondrial diseases in man and mouse. Science. 1999 Mar 5;283(5407):1482-8. doi: 10.1126/science.283.5407.1482. PMID: 10066162.
  14. Hirano M, Davidson M, DiMauro S. Mitochondria and the heart. Curr Opin Cardiol. 2001 May;16(3):201-10. doi: 10.1097/00001573-200105000-00008. PMID: 11357017.
  15. Lassègue B, Griendling KK. Reactive oxygen species in hypertension; An update. Am J Hypertens. 2004 Sep;17(9):852-60. doi: 10.1016/j.amjhyper.2004.02.004. PMID: 15363831.
  16. Taniyama Y, Griendling KK. Reactive oxygen species in the vasculature: molecular and cellular mechanisms. Hypertension. 2003 Dec;42(6):1075-81. doi: 10.1161/01.HYP.0000100443.09293.4F. Epub 2003 Oct 27. PMID: 14581295.
  17. Liang M. Hypertension as a mitochondrial and metabolic disease. Kidney Int. 2011 Jul;80(1):15-6. doi: 10.1038/ki.2011.84. PMID: 21673736.
  18. Hutchinson J, Crawford MH. Genetic determinants of blood pressure level among the Black Caribs of St. Vincent. Hum Biol. 1981 Sep;53(3):453-66. PMID: 7309028.
  19. DeStefano AL, Gavras H, Heard-Costa N, Bursztyn M, Manolis A, Farrer LA, Baldwin CT, Gavras I, Schwartz F. Maternal component in the familial aggregation of hypertension. Clin Genet. 2001 Jul;60(1):13-21. doi: 10.1034/j.1399-0004.2001.600103.x. PMID: 11531965.
  20. Yang Q, Kim SK, Sun F, Cui J, Larson MG, Vasan RS, Levy D, Schwartz F. Maternal influence on blood pressure suggests involvement of mitochondrial DNA in the pathogenesis of hypertension: the Framingham Heart Study. J Hypertens. 2007 Oct;25(10):2067-73. doi: 10.1097/HJH.0b013e328285a36e. PMID: 17885549.
  21. Wilson FH, Hariri A, Farhi A, Zhao H, Petersen KF, Toka HR, Nelson-Williams C, Raja KM, Kashgarian M, Shulman GI, Scheinman SJ, Lifton RP. A cluster of metabolic defects caused by mutation in a mitochondrial tRNA. Science. 2004 Nov 12;306(5699):1190-4. doi: 10.1126/science.1102521. Epub 2004 Oct 21. PMID: 15498972; PMCID: PMC3033655.
  22. Watson B Jr, Khan MA, Desmond RA, Bergman S. Mitochondrial DNA mutations in black Americans with hypertension-associated end-stage renal disease. Am J Kidney Dis. 2001 Sep;38(3):529-36. doi: 10.1053/ajkd.2001.26848. PMID: 11532685.
  23. Zinner SH, Levy PS, Kass EH. Familial aggregation of blood pressure in childhood. N Engl J Med. 1971 Feb 25;284(8):401-4. doi: 10.1056/NEJM197102252840801. PMID: 5540477.
  24. Havlik RJ, Feinleib M. Epidemiology and genetics of hypertension. Hypertension. 1982 Sep-Oct;4(5 Pt 2):III121-7. doi: 10.1161/01.hyp.4.5_pt_2.iii121. PMID: 7049926.
  25. Ruiz-Pesini E, Lott MT, Procaccio V, Poole JC, Brandon MC, Mishmar D, Yi C, Kreuziger J, Baldi P, Wallace DC. An enhanced MITOMAP with a global mtDNA mutational phylogeny. Nucleic Acids Res. 2007 Jan;35(Database issue):D823-8. doi: 10.1093/nar/gkl927. Epub 2006 Dec 18. PMID: 17178747; PMCID: PMC1781213.
  26. Abbott JA, Francklyn CS, Robey-Bond SM. Transfer RNA and human disease. Front Genet. 2014 Jun 3;5:158. doi: 10.3389/fgene.2014.00158. PMID: 24917879; PMCID: PMC4042891.
  27. Liu C, Yang Q, Hwang SJ, Sun F, Johnson AD, Shirihai OS, Vasan RS, Levy D, Schwartz F. Association of genetic variation in the mitochondrial genome with blood pressure and metabolic traits. Hypertension. 2012 Oct;60(4):949-56. doi: 10.1161/HYPERTENSIONAHA.112.196519. Epub 2012 Sep 4. PMID: 22949535; PMCID: PMC3753106.
  28. Liu Y, Li Y, Wang X, Ma Q, Zhu C, Li Z, Yin T, Yang J, Chen Y, Guan M. Mitochondrial tRNA mutations in Chinese hypertensive individuals. Mitochondrion. 2016 May;28:1-7. doi: 10.1016/j.mito.2016.02.007. Epub 2016 Feb 26. PMID: 26923935.
  29. Jia Z, Wang X, Qin Y, Xue L, Jiang P, Meng Y, Shi S, Wang Y, Qin Mo J, Guan MX. Coronary heart disease is associated with a mutation in mitochondrial tRNA. Hum Mol Genet. 2013 Oct 15;22(20):4064-73. doi: 10.1093/hmg/ddt256. Epub 2013 Jun 4. PMID: 23736300; PMCID: PMC3781636.
  30. Xue L, Wang M, Li H, Wang H, Jiang F, Hou L, Geng J, Lin Z, Peng Y, Zhou H, Yu H, Jiang P, Mo JQ, Guan MX. Mitochondrial tRNA mutations in 2070 Chinese Han subjects with hypertension. Mitochondrion. 2016 Sep;30:208-21. doi: 10.1016/j.mito.2016.08.008. Epub 2016 Aug 17. PMID: 27544295.
  31. Zhou M, Wang M, Xue L, Lin Z, He Q, Shi W, Chen Y, Jin X, Li H, Jiang P, Guan MX. A hypertension-associated mitochondrial DNA mutation alters the tertiary interaction and function of tRNALeu(UUR). J Biol Chem. 2017 Aug 25;292(34):13934-13946. doi: 10.1074/jbc.M117.787028. Epub 2017 Jul 5. PMID: 28679533; PMCID: PMC5572913.
  32. Li R, Liu Y, Li Z, Yang L, Wang S, Guan MX. Failures in mitochondrial tRNAMet and tRNAGln metabolism caused by the novel 4401A>G mutation are involved in essential hypertension in a Han Chinese Family. Hypertension. 2009 Aug;54(2):329-37. doi: 10.1161/HYPERTENSIONAHA.109.129270. Epub 2009 Jun 22. PMID: 19546379; PMCID: PMC2907155.
  33. Wang S, Li R, Fettermann A, Li Z, Qian Y, Liu Y, Wang X, Zhou A, Mo JQ, Yang L, Jiang P, Taschner A, Rossmanith W, Guan MX. Maternally inherited essential hypertension is associated with the novel 4263A>G mutation in the mitochondrial tRNAIle gene in a large Han Chinese family. Circ Res. 2011 Apr 1;108(7):862-70. doi: 10.1161/CIRCRESAHA.110.231811. PMID: 21454794.
  34. Jiang P, Wang M, Xue L, Xiao Y, Yu J, Wang H, Yao J, Liu H, Peng Y, Liu H, Li H, Chen Y, Guan MX. A Hypertension-Associated tRNAAla Mutation Alters tRNA Metabolism and Mitochondrial Function. Mol Cell Biol. 2016 Jun 29;36(14):1920-30. doi: 10.1128/MCB.00199-16. PMID: 27161322; PMCID: PMC4936059.
  35. Gong M, Hubner N. Molecular genetics of human hypertension. Clin Sci (Lond). 2006 Mar;110(3):315-26. doi: 10.1042/CS20050208. PMID: 16464173.
  36. Abais-Battad JM, Dasinger JH, Fehrenbach DJ, Mattson DL. Novel adaptive and innate immunity targets in hypertension. Pharmacol Res. 2017 Jun;120:109-115. doi: 10.1016/j.phrs.2017.03.015. Epub 2017 Mar 20. PMID: 28336371; PMCID: PMC5497567.
  37. Zhang RM, McNerney KP, Riek AE, Bernal-Mizrachi C. Immunity and Hypertension. Acta Physiol (Oxf). 2021 Jan;231(1):e13487. doi: 10.1111/apha.13487. Epub 2020 Jun 25. PMID: 32359222; PMCID: PMC7606441.
  38. Pérusse L, Rice T, Bouchard C, Vogler GP, Rao DC. Cardiovascular risk factors in a French-Canadian population: resolution of genetic and familial environmental effects on blood pressure by using extensive information on environmental correlates. Am J Hum Genet. 1989 Aug;45(2):240-51. PMID: 2757030; PMCID: PMC1683357.
  39. Fuentes RM, Notkola IL, Shemeikka S, Tuomilehto J, Nissinen A. Familial aggregation of blood pressure: a population-based family study in eastern Finland. J Hum Hypertens. 2000 Jul;14(7):441-5. doi: 10.1038/sj.jhh.1001049. PMID: 10918549.
  40. Longini IM Jr, Higgins MW, Hinton PC, Moll PP, Keller JB. Environmental and genetic sources of familial aggregation of blood pressure in Tecumseh, Michigan. Am J Epidemiol. 1984 Jul;120(1):131-44. doi: 10.1093/oxfordjournals.aje.a113862. PMID: 6741914.
  41. Hunt SC, Hasstedt SJ, Kuida H, Stults BM, Hopkins PN, Williams RR. Genetic heritability and common environmental components of resting and stressed blood pressures, lipids, and body mass index in Utah pedigrees and twins. Am J Epidemiol. 1989 Mar;129(3):625-38. doi: 10.1093/oxfordjournals.aje.a115175. PMID: 2916556.
  42. DeStefano AL, Gavras H, Heard-Costa N, Bursztyn M, Manolis A, Farrer LA, Baldwin CT, Gavras I, Schwartz F. Maternal component in the familial aggregation of hypertension. Clin Genet. 2001 Jul;60(1):13-21. doi: 10.1034/j.1399-0004.2001.600103.x. PMID: 11531965.
  43. Uehara Y, Shin WS, Watanabe T, Osanai T, Miyazaki M, Kanase H, Taguchi R, Sugano K, Toyo-Oka T. A hypertensive father, but not hypertensive mother, determines blood pressure in normotensive male offspring through body mass index. J Hum Hypertens. 1998 Jul;12(7):441-5. doi: 10.1038/sj.jhh.1000646. PMID: 9702929.
  44. Bengtsson B, Thulin T, Scherstén B. Familial resemblance in casual blood pressure--a maternal effect? Clin Sci (Lond). 1979 Dec;57 Suppl 5:279s-281s. doi: 10.1042/cs057279s. PMID: 540443.
  45. Austin SA, Vriesendorp FJ, Thandroyen FT, Hecht JT, Jones OT, Johns DR. Expanding the phenotype of the 8344 transfer RNAlysine mitochondrial DNA mutation. Neurology. 1998 Nov;51(5):1447-50. doi: 10.1212/wnl.51.5.1447. PMID: 9818878.
  46. Watson B Jr, Khan MA, Desmond RA, Bergman S. Mitochondrial DNA mutations in black Americans with hypertension-associated end-stage renal disease. Am J Kidney Dis. 2001 Sep;38(3):529-36. doi: 10.1053/ajkd.2001.26848. PMID: 11532685.
  47. Li Z, Liu Y, Yang L, Wang S, Guan MX. Maternally inherited hypertension is associated with the mitochondrial tRNA(Ile) A4295G mutation in a Chinese family. Biochem Biophys Res Commun. 2008 Mar 21;367(4):906-11. doi: 10.1016/j.bbrc.2007.12.150. Epub 2008 Jan 3. PMID: 18177739.
  48. Liu Y, Li R, Li Z, Wang XJ, Yang L, Wang S, Guan MX. Mitochondrial transfer RNAMet 4435A>G mutation is associated with maternally inherited hypertension in a Chinese pedigree. Hypertension. 2009 Jun;53(6):1083-90. doi: 10.1161/HYPERTENSIONAHA.109.128702. Epub 2009 Apr 27. PMID: 19398658; PMCID: PMC2907152.
  49. Liu Y, Chen Y. Mitochondrial tRNA Mutations Associated With Essential Hypertension: From Molecular Genetics to Function. Front Cell Dev Biol. 2021 Jan 22;8:634137. doi: 10.3389/fcell.2020.634137. PMID: 33585472; PMCID: PMC7874112.
  50. Majamaa-Voltti K, Peuhkurinen K, Kortelainen ML, Hassinen IE, Majamaa K. Cardiac abnormalities in patients with mitochondrial DNA mutation 3243A>G. BMC Cardiovasc Disord. 2002 Aug 1;2:12. doi: 10.1186/1471-2261-2-12. PMID: 12150714; PMCID: PMC119851.

Download Article
Received July 16, 2022.
Accepted August 16, 2022.
©2022 International Medical Research and Development Corporation.